Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SYRS
    4. >
  4. Valuation

Valuation

-
stocks logo
SYRS
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is SYRS Overvalued？

SYRS is now in the zone, suggesting that SYRS current forward PE ratio of -0.03 is considered compare with the five-year average of -2.37.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

SYRS Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SYRS.O
Syros Pharmaceuticals Inc
loss
Average P/E: 0.00
88.66%
2.30M
stocks logo
AWH.O
Aspira Women's Health Inc
loss
Average P/E: 0.00
52.17%
2.17M
stocks logo
AQB.O
AquaBounty Technologies Inc
loss
Average P/E: 0.00
2.40M
stocks logo
APDN.O
Applied DNA Sciences Inc
loss
Average P/E: 0.00
67.82%
2.02M
stocks logo
ELAB.O
ELEVAI Labs Inc
0.00
Average P/E: 0.00
-49.92%
2.44M
stocks logo
PLRZ.O
Polyrizon Ltd. Ordinary Shares
0.00
Average P/E: 0.00
2.81M

SYRS Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

SYRS FAQs

Is SYRS currently overvalued based on its P/E ratio?

According to the provided data, SYRS's 5-year historical average forward P/E ratio is -2.37. SYRS forward P/E ratio is -0.03, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for SYRS?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SYRS's Price to Sales (PS) ratio evolved?

The PS ratio increased from 42.22 to 204.89, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SYRS's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

SYRS PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-2.37
Current PE
-0.03
Overvalued PE
-0.23
Undervalued PE
-4.50

SYRS EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
0.00
Current EV
0.00
Overvalued EV
0.00
Undervalued EV
0.00

SYRS P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
42.40
Current PS
0.00
Overvalued PS
106.29
Undervalued PS
-21.48

SYRS Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SYRS.O
Syros Pharmaceuticals Inc
loss
Average P/E: 0.00
88.66%
2.30M
stocks logo
AWH.O
Aspira Women's Health Inc
loss
Average P/E: 0.00
52.17%
2.17M
stocks logo
AQB.O
AquaBounty Technologies Inc
loss
Average P/E: 0.00
2.40M
stocks logo
APDN.O
Applied DNA Sciences Inc
loss
Average P/E: 0.00
67.82%
2.02M
stocks logo
ELAB.O
ELEVAI Labs Inc
0.00
Average P/E: 0.00
-49.92%
2.44M
stocks logo
PLRZ.O
Polyrizon Ltd. Ordinary Shares
0.00
Average P/E: 0.00
2.81M

SYRS Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SYRS undervalued？Is SYRS overvalued compared to its competitors？

SYRS FAQs

Is SYRS currently overvalued based on its P/E ratio?

According to the provided data, SYRS's 5-year historical average forward P/E ratio is -2.37. SYRS forward P/E ratio is -0.03, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for SYRS?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SYRS's Price to Sales (PS) ratio evolved?

The PS ratio increased from 42.22 to 204.89, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SYRS's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SYRS undervalued？Is SYRS overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free